Annual report pursuant to Section 13 and 15(d)

Segment Information

v2.4.1.9
Segment Information
12 Months Ended
Dec. 31, 2014
Segment Information:  
Segment Information

Note 20 – Segment Information

 

The Company is operating an acquisition and investment business.  Majority owned subsidiaries of 51% or more are consolidated.  The Company has determined that beginning in January 2014 there are two reportable segments, which are 1) the cannabis and medical marijuana segment which includes the receivable from Bhang of $1,500,000, the convertible note receivable from Electrum Partners and the operation of MCB, a subsidiary in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their trash related operating costs.  The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below.  In 2013 the Company was not required to consolidate any of its subsidiaries.

 

Cannabis and Medical Marijuana Segment

Legacy Investments

Corporate and Eliminations

Consolidated

2014

Sales to unaffiliated customers

$        5,390

$  2,144,176

$              -

$  2,149,566

 

 

 

 

 

 

 

 

Intersegment sales

-

-

-

-

Net sales

5,390

2,144,176

-

2,149,566

 

 

 

 

Cannabis and Medical Marijuana Segment

 

Legacy Investments

 

Corporate and Eliminations

 

Consolidated

Income before taxes

(69,332)

76,067

(413,837)

(407,102)

 

Total assets

$  1,626,566

$   1,106,498

$ 1,261,326

$   3,994,390

Property additions

44,978

25,007

7,103

77,088

Interest expense

21,387

772

22,159

Depreciation and amortization

3,126

29,948

2,450

35,524